Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$6.7 - $24.21 $25,225 - $91,150
3,765 Added 4.07%
96,236 $2.32 Million
Q4 2022

Feb 14, 2023

BUY
$4.52 - $10.57 $100,985 - $236,154
22,342 Added 31.86%
92,471 $977,000
Q3 2022

Nov 18, 2022

BUY
$3.43 - $5.62 $3,488 - $5,715
1,017 Added 1.47%
70,129 $316,000
Q2 2022

Aug 15, 2022

BUY
$3.65 - $7.3 $14,172 - $28,345
3,883 Added 5.95%
69,112 $276,000
Q1 2022

May 16, 2022

SELL
$3.4 - $7.88 $18,179 - $42,134
-5,347 Reduced 7.58%
65,229 $477,000
Q4 2021

Feb 15, 2022

BUY
$5.59 - $7.39 $9,452 - $12,496
1,691 Added 2.45%
70,576 $397,000
Q3 2021

Nov 15, 2021

SELL
$5.66 - $8.33 $42,931 - $63,183
-7,585 Reduced 9.92%
68,885 $441,000
Q2 2021

Aug 16, 2021

SELL
$6.71 - $11.04 $23,921 - $39,357
-3,565 Reduced 4.45%
76,470 $645,000
Q1 2021

May 18, 2021

BUY
$10.12 - $19.45 $80,949 - $155,580
7,999 Added 11.1%
80,035 $840,000
Q3 2020

Nov 17, 2020

BUY
$10.34 - $15.2 $84,167 - $123,728
8,140 Added 12.74%
72,036 $924,000
Q2 2020

Aug 17, 2020

BUY
$7.81 - $17.0 $499,027 - $1.09 Million
63,896 New
63,896 $902,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.